Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Financial Result for QTR2

Date: 03.11.2026 Department of Corporate Services, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. Ref: Scrip Code: 526075 Subject: Intimation of Board Meeting to be held on 13th November, 2026. Dear Sir/Madam, Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on 13th November, 2026, inter alia; 1. To consider and approve Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter and Half Year ended on 30th September, 2026. 2. Any other agendas as may be considered necessary with the permission of the chair. Further, in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company’s equity shares from October 01, 2026 till the expiry of 48 hours from the date of said financial results are made public. This is for your information and record. Thanking you, Yours Faithfully FOR REKVINA LABORATORIES LIMITED Surbhit Shah Director DIN: 01993300 CIN: L24231GJ1988PLC01145 Regd. Office: 3rd floor 5 Laxmi Society, B/h Baroda Heart Institute, O.P. Road, Vadodara – 390007 Email Id: info@rekvinalaboratories.com, rekvinalimited@gmail.com Cont. No.: 0265-2362966